Qube Research & Technologies (QRT)
PRQR icon

Qube Research & Technologies (QRT)’s ProQR Therapeutics PRQR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33
Closed -$55 – 3938
2024
Q2 		$55 Hold
33
– – ﹤0.01% 3497
2024
Q1 		$75 Hold
33
– – ﹤0.01% 4196
2023
Q4 		$65 Hold
33
– – ﹤0.01% 4053
2023
Q3 		$43 Buy
+33
New +$52 ﹤0.01% 3827

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRQR Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of ProQR Therapeutics (PRQR) in Q3 2024, closing a stake of 33 shares — an estimated $55 sold.

Qube Research & Technologies (QRT) first reported a position in PRQR in Q3 2023 and held it in 4 quarters. The position peaked at $75 in Q1 2024. 47 funds tracked by Wall St. Rank hold PRQR as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining ProQR Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 33 ProQR Therapeutics shares in Q3 2024, an estimated $55.
  • Qube Research & Technologies (QRT) first reported a position in ProQR Therapeutics in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s ProQR Therapeutics position peaked at $75 in Q1 2024.
  • 47 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.